Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour first Wegovy injection starts at the 0.25 mg dose, given once a week by subcutaneous injection into the abdomen, thigh or upper arm. The pen is pre-filled and pre-set — you do not draw up or measure anything. Clinical guidance from the NHS semaglutide medicines page confirms this low starting dose is a tolerability step, not a therapeutic target; your prescriber titrates upward from there. These are prescription-only medicines, so the injections happen under the ongoing supervision of a clinician who reviews your progress before each repeat.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, enrolled adults who began semaglutide at exactly the dose you will start: 0.25 mg once weekly, titrated upward every four weeks under clinical oversight. That controlled, stepped approach was not incidental — it was the designed mechanism for keeping gastrointestinal side effects manageable while the body adjusted. Your first injection replicates it. Preparation matters, and the official guidance is reassuringly specific.
Take the pen from the fridge and let it sit at room temperature for around 30 minutes before injecting; a cold pen can make the injection more uncomfortable than it needs to be. Check the liquid through the viewing window: it should be clear or almost clear and colourless to slightly yellow. A cloudy, discoloured or particulate solution should not be used. Remove the pen cap only when you are ready. Many people assume the pen needs priming before each use, as syringes do. It does not, and if you want a full walkthrough of the device before you begin, our guide to getting your Wegovy pen ready for first use covers every step in detail.
Wash your hands thoroughly, then clean the chosen skin site with an alcohol swab and let it dry completely before injecting. Wet skin can sting.
Pinch a fold of skin lightly between your fingers and hold the pen against the skin at a 90-degree angle. Press the injection button firmly until it clicks, then hold the pen in place for at least six seconds, this allows the full dose to be delivered and helps prevent leakage back through the needle track. Release the button, then lift the pen straight away from the skin.
The needle is fine and short; most people describe the sensation as a mild scratch rather than a sting. If you feel a sharp pinch, the site may have been tensed, relaxing the muscle in the thigh, for instance, makes a real difference. Rotate injection sites week to week, and within each site avoid exactly the same spot as the week before; this reduces the small risk of lipohypertrophy, a localised thickening of the fat layer that can affect absorption. For a step-by-step guide to your first injection of Wegovy, including site selection and technique tips, we have a dedicated page that walks you through the process.
After the injection, apply gentle pressure with a dry swab if there is any minor bleeding, but do not rub the area. Do not recap the needle. The used pen goes straight into a dedicated sharps bin; standard household bins are not safe for used medical sharps, and NHS guidance asks that you return your full sharps bin to a pharmacy or household waste site that accepts them.
Because each pen contains one dose, storage after first use is straightforward: the pen is finished and should be discarded. Future pens stay in the fridge until needed. The Patient Information Leaflet included with your pack gives the exact number of hours a pen may safely be kept at room temperature if refrigeration is temporarily unavailable, refer to that document rather than any general estimate, because the window is specific to this formulation. Storing Wegovy correctly matters for both safety and effectiveness; temperature excursions can degrade the active medicine without any visible sign. If you would also like a complete overview of how to use Wegovy for the first time, covering everything from unpacking the pen to completing the injection, that guide brings all of the key steps together in one place.
Travel, GP appointments and gym bags all create storage challenges. Plan ahead: an insulated cool bag with a gel ice pack (not direct ice) works well for short journeys. Your prescriber can advise on longer travel periods during a clinical review.
Nausea is the most commonly reported effect after a first injection, typically mild, appearing within hours and easing over a few days. Diarrhoea, constipation and a reduced appetite are also common at the start. These are well-documented in the trial data and tend to lessen as the body settles at the starter dose. Eating a smaller, lower-fat meal on injection day can help.
Contact a doctor promptly if you experience severe or persistent stomach pain, particularly pain that radiates to the back, this is a symptom the MHRA flagged in a January 2026 Drug Safety Update as a warning sign for acute pancreatitis, an uncommon but serious reaction. Symptoms of a severe allergic reaction (widespread rash, swelling, breathing difficulty) also require urgent medical attention. If you ever want to report a side effect yourself, the MHRA Yellow Card scheme is open to patients as well as clinicians.
You can read a broader overview of the medicine and the treatment journey on the Wegovy treatment page, or explore all weight-loss options we support if you are still deciding which route suits you. Semaglutide (Wegovy) is sometimes confused with Ozempic, which contains the same active ingredient but holds a different UK licence, one worth understanding clearly before starting. Our clinical team reviews every patient individually; a prescriber, not software, reads your consultation answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.